| The results showed that miR-137 can act as a tumor suppressor in uveal melanoma cell proliferation through downregulation of the targets MITF and CDK6. | skin, |
| miR-137 functionas as a tumor suppressor by targeting CtBP1 to inhibit epithelial-mesenchymal transition and inducing apoptosis of melanoma cells. | skin, |
| miR-137 acts as a tumor suppressor in malignant melanoma and reveals that miR-137 regulates multiple targets including c-Met, YB1, EZH2, and MITF. | skin, |
| microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18 | lung, |
| Our results demonstrate that miR-137 acts as a tumor-suppressive miRNA in colorectal cancers and negatively regulates oncogenic Musashi-1 | colorectal, |
| Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression | colorectal, |
| Results showed that miR-137 expression was significantly downregulated in papillary thyroid carcinoma (PTC) tissues, and its expression was correlated with TNM stage and lymph node metastasis. It provides evidence that miR-137 may function as a tumor suppressor in PTC by targeting CXCL12. | thyroid, |
| our findings revealed that its functions, in part, are through up-regulating several miRNAs, including miR-137, an important component of tumor suppressors in NSCLC | lung, |
| miR-137 plays tumor suppressor roles in gastric cancer cell lines by targeting KLF12 and MYO1C | gastric, |
| These results indicate that miR-137 acted as a tumor suppressor in tongue squamous cell carcinoma by targeting SP1. | tongue, |
| MicroRNA-137 acts as a tumor suppressor in osteosarcoma by targeting enhancer of zeste homolog 2 | osteosarcoma, |
| miR-137 acts as a tumor suppressor via inhibiting CXCL12 in human glioblastoma | glioblastoma, |
| MiR-137 functions as a tumor suppressor in pancreatic cancer by targeting MRGBP | pancreatic, |
| miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation | endometrial, |
| miR-137 functions as a tumor suppressor gene in pituitary adenoma by targeting AKT2 | pituitary, |
| MiR-137 serves as a tumor suppressor, which can be considered a potential therapeutic target in clear-cell renal cell carcinoma. | kidney, |
| these findings indicate that miR-137 functions as a tumor suppressor by inhibition of AEG-1. | None |
| miR-137/197 act as tumor suppressors in mediating apoptosis in multiple myeloma cells by targeting MCL-1. | None |
| miR-137 acts as a tumor suppressor in astrocytoma by targeting RASGRF1 | None |